Interleukin-6 as an enhancer of anti-angiogenic therapy for ovarian clear cell carcinoma

Ovarian clear cell carcinoma (OCCC) is a subtype of epithelial ovarian cancer (EOC) that is associated with elevated interleukin-6 (IL-6) expression, resistance to chemotherapy, and increased mortality. Although bevacizumab (Bev) is a widely used anti-angiogenic agent for EOC, the efficacy of Bev an...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Sci Rep
Main Authors: Seki, Toshiyuki, Yanaihara, Nozomu, Shapiro, Jason Solomon, Saito, Misato, Tabata, Junya, Yokomizo, Ryo, Noguchi, Daito, Kuroda, Takafumi, Kawabata, Ayako, Suzuki, Jiro, Takahashi, Kazuaki, Matsuzawa, Haruka, Miyake, Misayo, Takenaka, Masataka, Iida, Yasushi, Yanagida, Satoshi, Okamoto, Aikou
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8032732/
https://ncbi.nlm.nih.gov/pubmed/33833265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-86913-9
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares